BACKGROUND: The expected survival after the EUS-FNA diagnosis of @entity409 from @entity788 is not known. OBJECTIVE: To report overall and 1-year survival in these @entity1 . DESIGN: Retrospective cohort series. SETTING: Tertiary referral hospital. @entity1 : Consecutive subjects with newly diagnosed @entity788 from June 1998 and March 2008 in whom EUS-FNA of the liver or ascitic fluid confirmed hepatic @entity3 or @entity5 . INTERVENTIONS: Calculation of survival after diagnosis by using the Social Security Death Index. MAIN OUTCOME MEASUREMENTS: Survival after EUS-FNA diagnosis of @entity5 . RESULTS: EUS-FNA identified liver @entity3 and @entity5 from primary @entity788 in 75 and 13 @entity1 , respectively, and all 88 died during follow-up. For all 88 @entity1 , the 1-year survival rate and median survival were 3.4% (95% CI, 1.1%-10.4%) and 82 days (range 2-754 days), respectively. The 1-year survival rates for those with liver @entity3 (4.0% [95% CI, 1.3%-12.1%]) and for those with @entity5 (0% [95% CI, 0-24.7%]) were similar (P = 1.0). The median survival for @entity1 with liver @entity3 of 83 days (range 2-754 days) was similar to that for those with @entity5 (64 days; range 2-153 days) (P = .13). No clinical variable considered predicted survival of more than, less than, or 3 months. LIMITATIONS: Retrospective series with variable treatment for @entity5 . CONCLUSIONS: In @entity1 with @entity788 , identification of @entity409 by EUS-FNA is associated with a very poor prognosis.

Survival in @entity1 with XXXX after the diagnosis of @entity409 by EUS-FNA.

@entity1 :: ('9606', 'Species') :: ['patients', 'PATIENTS'] @entity788 :: ('MESH:D010190', 'Disease') :: ['pancreatic cancer'] @entity5 :: ('MESH:D009369', 'Disease') :: ['malignant ascites', 'stage IV pancreatic cancer', 'malignancy'] @entity409 :: ('MESH:D008107', 'Disease') :: ['malignant ascites or liver metastases'] @entity3 :: ('MESH:D009362', 'Disease') :: ['metastases']
@entity788 :: (MESH:D010190,Disease) :: ['pancreatic cancer']
